Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 18;49(5):649–652. doi: 10.1016/j.ajic.2020.10.009

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig 1 — Odds of serological reactivity based on symptoms and symptom clusters. (A and B) Depict (age, gender and facility) adjusted odds ratios (aORs) on a log10 scale for seropositivity of individual symptoms among the entire population (1A) or among individuals with a negative or no NAAT test prior to serological testing (1B). Anosmia, dizziness, nausea, and vomiting are not reported in 1B due to extremely broad confidence intervals. (C and D) Depict aORs (on a log10 scale) for seropositivity of symptom clusters (Appendix A) among the entire population (1C) or among individuals with a negative or no NAAT test prior to serological testing(1D). Anosmia, loss of smell/taste; SOB, shortness of breath/difficulty breathing; PHAC, Public Health Agency of Canada; US CDC, United States Centre for Disease Control; European CDC, European Centre for Disease Prevention and Control; WHO, World Health Organization.